The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes.

Zheng W, Yao C, Wang Z, Zhang C

Open source

DOI
10.1186/s12885-026-16674-z
Published
2026 Aug 7
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16674-z,
  title = {The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes.},
  author = {Zheng W and Yao C and Wang Z and Zhang C},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-16674-z},
  url = {https://doi.org/10.1186/s12885-026-16674-z}
}

RIS

TY  - JOUR
TI  - The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes.
AU  - Zheng W
AU  - Yao C
AU  - Wang Z
AU  - Zhang C
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-16674-z
UR  - https://doi.org/10.1186/s12885-026-16674-z
ER  - 

APA

W, Z., C, Y., Z, W., & C, Z. (2026). The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes.. BMC cancer. https://doi.org/10.1186/s12885-026-16674-z

Source records